1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Utah >
  6. ImmunoPrecise Acquires Carterra s LSA Instrument

M&A Deal Summary

ImmunoPrecise Acquires Carterra s LSA Instrument

On March 20, 2024, ImmunoPrecise acquired technology hardware company Carterra s LSA Instrument from Carterra

Acquisition Highlights
  • This is ImmunoPrecise’s 1st transaction in the Technology Hardware sector.
  • This is ImmunoPrecise’s 1st transaction in the United States.
  • This is ImmunoPrecise’s 1st transaction in Utah.

M&A Deal Summary
Date 2024-03-20
Target Carterra s LSA Instrument
Sector Technology Hardware
Buyer(s) ImmunoPrecise
Sellers(s) Carterra
Deal Type Divestiture

Target

Carterra s LSA Instrument

Salt Lake City, Utah, United States
Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ImmunoPrecise

Victoria, British Columbia, Canada
Category Company
Founded 1983
Sector Life Science
Employees102
Revenue 25M CAD (2025)
DESCRIPTION

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise was founded in 1983 and is based in Victoria, Canada.

DEAL STATS #
Overall 3 of 3
Sector: Technology Hardware M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Utah M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-29 BioStrand

Diepenbeek , Belgium

BioStrand is a provider of cloud-based solution to perform multi-omics research faster and more accurately, with more effective data analysis. BioStrand is based in Diepenbeek, Belgium.

Buy €20M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-08-06 IPA Europe

Oss, Netherlands

IPA Europe is an international non-profit organisation that addresses policy issues related to probiotics in Europe. IPA Europe is based in Oss, Netherlands.

Sell $12M

Seller(S) 1

SELLER

Carterra

Salt Lake City, Utah, United States
Category Company
Founded 2005
Sector Medical Products
DESCRIPTION

Carterra is a provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra was founded in 2005 and is based in Salt Lake City, Utah.

DEAL STATS #
Overall 2 of 2
Sector: Technology Hardware M&A 1 of 1
Type: Divestiture M&A Deals 2 of 2
State: Utah M&A 2 of 2
Country: United States M&A 2 of 2
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-20 Carterra LSA Instrument

Salt Lake City, Utah, United States

Carterra LSA Instrument provides an antibody discovery and characterization platform utilizing Surface Plasmon Resonance (HT-SPR) technology and has quickly made it the standard in 16 of the largest 20 pharmaceutical companies, biotechs, CROs, and government labs.

Sell -
Mergr

Solution for

Product

Company

Legal